Treatment received by presenting features
| . | Chemotherapy, no. (%) . | Related donor BMT, no. (%) . | MUD BMT, no. (%) . |
|---|---|---|---|
| Total | 351 | 76 | 25 |
| Age, y | |||
| 1 | 38 (88%) | 5 (12%) | 0 (0%) |
| 2 | 188 (75%) | 51 (20%) | 12 (5%) |
| 10+ | 125 (79%) | 20 (13%) | 13 (8%) |
| Sex | |||
| M | 242 (75%) | 61 (19%) | 18 (6%) |
| F | 109 (83%) | 15 (11%) | 7 (5%) |
| WBC count, ×109/L | |||
| <100 | 92 (77%) | 14 (12%) | 13 (11%) |
| 100 | 83 (81%) | 17 (16%) | 3 (3%) |
| 150 | 49 (75%) | 15 (23%) | 1 (2%) |
| 200 | 36 (80%) | 8 (18%) | 1 (2%) |
| 250 | 91 (76%) | 22 (18%) | 7 (6%) |
| Immunophenotype | |||
| T-ALL | 126 (75%) | 37 (22%) | 4 (2%) |
| C, pre-B, or null | 200 (79%) | 35 (14%) | 17 (7%) |
| Ploidy | |||
| Normal | 59 (80%) | 13 (18%) | 2 (3%) |
| Hypodiploid | 19 (76%) | 5 (20%) | 1 (4%) |
| Pseudodiploid | 105 (72%) | 25 (17%) | 15 (10%) |
| Low hyperdiploid | 21 (78%) | 4 (15%) | 2 (7%) |
| High hyperdiploid | 30 (86%) | 3 (9%) | 2 (6%) |
| Ph+ ve | |||
| No | 222 (79%) | 47 (17%) | 11 (4%) |
| Yes | 12 (46%) | 3 (12%) | 11 (42%) |
| . | Chemotherapy, no. (%) . | Related donor BMT, no. (%) . | MUD BMT, no. (%) . |
|---|---|---|---|
| Total | 351 | 76 | 25 |
| Age, y | |||
| 1 | 38 (88%) | 5 (12%) | 0 (0%) |
| 2 | 188 (75%) | 51 (20%) | 12 (5%) |
| 10+ | 125 (79%) | 20 (13%) | 13 (8%) |
| Sex | |||
| M | 242 (75%) | 61 (19%) | 18 (6%) |
| F | 109 (83%) | 15 (11%) | 7 (5%) |
| WBC count, ×109/L | |||
| <100 | 92 (77%) | 14 (12%) | 13 (11%) |
| 100 | 83 (81%) | 17 (16%) | 3 (3%) |
| 150 | 49 (75%) | 15 (23%) | 1 (2%) |
| 200 | 36 (80%) | 8 (18%) | 1 (2%) |
| 250 | 91 (76%) | 22 (18%) | 7 (6%) |
| Immunophenotype | |||
| T-ALL | 126 (75%) | 37 (22%) | 4 (2%) |
| C, pre-B, or null | 200 (79%) | 35 (14%) | 17 (7%) |
| Ploidy | |||
| Normal | 59 (80%) | 13 (18%) | 2 (3%) |
| Hypodiploid | 19 (76%) | 5 (20%) | 1 (4%) |
| Pseudodiploid | 105 (72%) | 25 (17%) | 15 (10%) |
| Low hyperdiploid | 21 (78%) | 4 (15%) | 2 (7%) |
| High hyperdiploid | 30 (86%) | 3 (9%) | 2 (6%) |
| Ph+ ve | |||
| No | 222 (79%) | 47 (17%) | 11 (4%) |
| Yes | 12 (46%) | 3 (12%) | 11 (42%) |
Patients with pseudodiploid and Ph+ more likely to have MUD BMT (MUD vs chemotherapy and ABMT, P = .04 andP < .00005, respectively).